Objectives: Diabetes results from inadequate insulin production from pancreatic ß-cells. Islet cell replacement is an effective approach for diabetes treatment; however, it is not sufficient for all diabetic patients. Thus, finding a new source with effective maturation of ß-cells is the major goal of many studies. MicroRNAs are a class of small noncoding ribonucleic acid that regulate gene expression through posttranscriptional mechanisms. MicroRNA-7 has high expression level during pancreatic islet development in humans, thereby playing a critical role in pancreatic β-cell function. We study aimed to develop a protocol to differentiate human-induced pluripotent stem cells efficiently into isletlike cell clusters in vitro by using microRNA-7. Materials and Methods: Human-induced pluripotent stem cell colonies were transfected with hsamicroRNA-7 by using siPORT NeoFX transfection agent. Total ribonucleic acid was extracted 24 and 48 hours after transfection. The expression of transcription factors which were important during pancreases development was also performed. On the third day, the potency of the clusters was assessed in response to high glucose levels. Diphenylthiocarbazone was used to identify the existence of the ß-cells. The presence of insulin and Neurogenin-3 proteins was investigated by immunocytochemistry. Results: Morphologic changes were observed on the first day after chemical transfection, and cell clusters were formed on the third day. The expression of pancreatic specific transcription factors was increased on the first day and significantly increased on the second day. The isletlike cell clusters were positive for insulin and Neurogenin-3 proteins in immunocytochemistry. The clusters were stained with Diphenylthiocarbazone and secreted insulin in a glucose challenge test. Conclusions: MicroRNA-7 transcription factor net-work is important in pancreatic endocrine differe-ntiation. Chemical transfection with microRNA-7 can differentiate human induced pluripotent stem cells into functional isletlike cell clusters in a short time.
Introduction
Type 1 diabetes mellitus is an autoimmune disease in which insulin-secreting β-cells in pancreatic islets are destroyed by autoimmune attacks, leading to the lack of insulin production. In contrast, type 2 diabetes mellitus occurs when the pancreas generates insufficient amounts of insulin and/or body tissues become resistant to normal or high levels of insulin. 1 Cell therapies for diabetes mainly focus on whole pancreas transplant or introduction of pancreatic islets into the portal vein of a diabetic individual. 2 Although these techniques have been reported to be highly effective, they are impeded by immune rejection and the lack of primary tissues for transplant. The concept of autologous grafting of insulin-secreting cells derived from the patient's tissue stem cells, particularly from bone marrow or liver, is highly attractive. 2 However, these cell transplants in animals might be accompanied by problems with restricted growth capacity, low insulin expression levels, and poor or nonexistent insulin secretion. 3 Transplant of induced pluripotent stem (iPS) cells from embryonic stem (ES) cells was sufficient to normalize the blood glucose level in diabetic mice, but tumor formation was reported. 4 Yet, the role of human ES cells has been suggested by more recent studies. Human ES cells are highly potent for treatment of various diseases, but the generation of these cells is controversial ethically. Therefore, generation of patient specific pluripotent stem cells from somatic cells is not associated with immune rejection or ethical controversy and holds promise for regenerative medicine and biomedical research. 5 Reprogramming of somatic cells to pluripotent ES cell-like cells, named IPS cells, has been attained by expression of defined transcription factors, including the combination of OCT4, Klf4, Sox2, and c-Myc or OCT4, Sox2, Nanog, and Lin28. 6 The microRNAs (miRNAs or miRs) are a type of small noncoding RNAs with 18 to 24 nucleotides which were first described as a part of a cascade resulting in posttranscriptional gene silencing in Caenorhabditis elegans > 15 years ago. 7 The microRNAs have been identified in mammals, including humans, and fish, frogs, insects, worms, flowers, and viruses. The microRNAs act posttranscriptionally in these organisms to reduce the levels of multiple target transcripts and their encoded proteins. 8, 9 They also regulate major cellular functions, including cell proliferation, apoptosis, differentiation, timing of developmental transitions, and organ development. 10 Among a subset of microRNAs which were differentially expressed in the islets (islet/acinar ratio > 150), microRNA-7 was the most abundant in rat and human islets. The microRNA-7 is a highly conserved microRNA which mostly is limited to endocrine tissues, including the islets of zebra fish, human and rodent pancreatic islets, and human pituitary glands. [11] [12] [13] It is expressed at high levels in the human adult pancreas and endocrine cells during human pancreatic development. 13, 14 The microRNA-7 is encoded by a single gene in flies and 3 different genomic loci in humans and mice (mmu-microRNA7a-2 at Chr7 and mmu-microRNA-7b at Chr17). 15 Recent studies on microRNA-7 have identified the important role in the development of pancreatic endocrine portion and the generation, differentiation, and function of β-cells. It is important that human iPS cells can be derived directly from patients, and in case of successful differentiation, they can be used in pancreatic treatment without any need for immunosuppressive drugs. Thus, the present study aimed to investigate the effect of increasing microRNA-7 concentration in human iPS cells by chemical transfection on differentiation of the cells to islet-like cell clusters (ILCs).
Materials and Methods

Cell culture
Human iPS cell line (RSCB0082TM) was obtained from Iranian Royan Stem Cell Bank. 16 The iPS cell line had been prepared by reprogramming a 42-yearold man's dermal fibroblast cells. The iPS cells were cultured on mitotically inactivated mouse embryonic fibroblasts (MEF). The culture media contained 70% Dulbecco Modified Eagle Medium (DMEM)/F12 medium (Gibco, Life Technologies, Bothell, MA, USA) supplemented with 20% knockout serum (KOSR, Gibco), 4 ng/mL basic fibroblast growth factor (bFGF) (Gibco), 0.1 mM 2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA), 0.1 mM nonessential amino acids (Gibco), 5 mg/mL insulin, 5 mg/mL transferrin, 5 μg/mL selenium, insulintransferrin-selenium (ITS) (Gibco), 100 IU/mL penicillin, and 100 IU/mL streptomycin (SigmaAldrich). The cells were incubated at 37ºC with 5% carbon dioxide.
In vitro differentiation of pancreatic isletlike cell clusters
The 4-stage protocol for in vitro differentiation of human iPS cells into ILCs (Figure 2 ) was modified from a previously published protocol. 17, 18 Stage 1: Formation of embryoid bodies (EBs). The iPS cells were dissociated by using trypsinethylenediaminetetraacetic acid (EDTA), and 2000 cells were cultured in 20 μL culture media (80% DMEM/F12; 20% fetal bovine serum [FBS] ) with a hanging drop approach for 3 days.
Stage 2: Induction of pancreatic progenitors. For 2 weeks, the EBs were cultured in tissue culture plates that were coated with 0.1% gelatin in DMEM/F12 medium containing ITS.
Stage 3: Expansion of pancreatic progenitors. The cells were dissociated with 0.05% trypsin-EDTA (Invitrogen, Carlsbad, CA, USA) and plated on plastic tissue culture plates in DMEM/F12 medium supplemented with 1% nitrogen (GIBCO), 2% B27 (GIBCO), (and 10 ng/mL bFGF (Gibco) for 7 days.
The culture plates were coated with 0.1% gelatin (Sigma-Aldrich).
Stage 4: Formation of ILCs. The cells were incubated in low DMEM supplemented with 1% nitrogen and 2% B27 supplements for 7 days. Then, bFGF was removed and 10 mM of nicotinic acid (Sigma-Aldrich) was added. 
Optimization of chemical transfection
hsa-microRNA-7 transfection
For preparing iPS cell colonies, we dissociated iPS cell colonies by incubating an IPS flask with collagenase IV (0.5 mg/mL) (Gibco) for 20 minutes. The colonies without MEF were cultured for 24 hours in 24-well plates containing DMEM/F12 supplemented with 10% FBS, penicillin 100 U/mL, and streptomycin 100 μg/mL. After 24 hours, the iPS cell colonies were attached to the plate. The hsa -microRNA-7 with accession number MIMAT0000252, as miRBase database, was purchased (Ambion). The mature microRNA-7 sequence was as follows: UGGAAGACUAGU GAUUUUGUUGU (Ambion). The IPS colonies were transfected with hsa-microRNA-7 by using transfection agent (siPORT NeoFX, Invitrogen), and the colonies were cultured in 24-well plates containing DMEM/F12 supplemented with 10% FBS, penicillin 100 U/mL, and streptomycin 100 μg/mL for 24 hours and incubated at 37 o C in a humidified atmosphere containing 5% carbon dioxide. The nontargeting negative control (FAM-labeled Pre-microRNA, Ambion) was used as negative control to monitor transfection efficiency during optimization of transfection conditions.
Analysis of microRNA-7 gene expression by realtime polymerase chain reaction (quantitative polymerase chain reaction)
For microRNA detection, the total RNA was extracted from IPS before (day 0) and 24 hours after (day 1) transfection with hsa-microRNA-7 (Trizol, Gibco). The cDNA was synthesized with a kit (Micro RNAs cDNA Synthesis Kit, Pars Genome, Tehran, Iran) according to the instructions from the manufacturer. Quantitative real-time polymerase chain reaction (RT-PCR) (ABI Prism7500, StepOnePlus, Life Technologies) was performed to evaluate changes in levels of microRNA-7 using a kit (SYBR Green RT-PCR Kit, Pars Genome) according to the instructions from the manufacturer. The cDNA was synthesized and normalized by U6 gene. The reaction conditions included preheating at 95ºC for 5 minutes. In stage 2, denaturation at 95ºC for 5 seconds, annealing for 20 seconds, and extension at 72ºC for 30 seconds for 40 cycles took place. Any amplification > 35 cycles (cycle threshold [Ct]) was considered negative.
In the final stage, a melting curve was generated to verify amplification product specificity. The relative expression levels of microRNA-7 were calculated according to the formula 2 -DDCT.
Analysis of pancreatic specific transcription factor gene expression by real-time polymerase chain reaction Extraction of total RNA from the iPS cells treated with bFGF was performed at the end of each stage. The total RNA was extracted from 2 × 10 5 cells before (day 0) and on the first and second days after transfection using an RNA extraction kit (MiniRNease RNA extract kit, CinnaGen, Tehran, Iran) according to instructions from the manufacturer. The cDNA was synthesized using M-MLV reverse transcriptase (CinnaGen) from 1 μg total RNAs. Realtime quantitative polymerase chain reaction (qPCR) primers, conditions, and product sizes were summarized ( Table 1 ). The cDNA was added to SYBR Green I (SG) (SYBR Green master mix, TaKaRa, Takara Shuzo, Otsu, Japan). The PCR amplifications were performed with an RT-PCR detection system (ABI Prism7500, StepOnePlus, Life Technologies). In RT-PCR analysis, all experiments were performed in triplicate. Endogenous control was β-actin. Amplification was as follows: predenaturing at 95ºC for 5 minutes. In stage 2, denaturation at 95ºC for 1 minute; and annealing for 1 minute for 40 cycles took place.
Any amplification > 35 cycles (Ct) was considered negative. A melting curve was generated to verify amplification product specificity.
Immunocytochemistry
We added 10 4 cells to a slide for 3 minutes, cytocentrifuged the cells (CytospinTM 4 centrifuge, Thermo Fisher Scientific, Waltham, MA, USA) at 1000 rpm, and fixed the cells in acetone. Peroxidase inactivation was performed by immersion in 3% hydrogen peroxide, and cells were washed in phosphate-buffered saline (PBS) for 5 minutes. The cells were blocked with 1% blocking solution (1% bovine serum albumin [BSA] and detergent [0.1% Triton X-100 (Dako, Glostrup, Denmark)] in PBS) for 20 minutes. The slides were incubated with antineurogenin-3 antibody (3B5) (Abcam, Cambridge, UK) (dilution 1:1000) and anti-insulin (Dako) for 40 minutes at room temperature. After washing in PBS, a secondary antibody was added (En VisionTM Systems, Dako). The slides were washed with PBS for 10 minutes, visualized with diaminobenzidine (Dako), and counterstained with hematoxylin (Sigma-Aldrich, Germany).
Diphenylthiocarbazone staining
Diphenylthiocarbazone (DTZ) (Dithizone, SigmaAldrich), a zinc-binding chemical dye that selectively stained live pancreatic β-cells bright crimson red, was used for identification of ILCs. The ILCs were incubated with 10 μL DTZ at 37ºC for 30 minutes and viewed under an inverted phase contrast microscope (Olympus IX 70, Tokyo, Japan). 
Insulin release
The adherent clusters produced through this procedure on the third day were incubated with Krebs-Ringer Bicarbonate HEPES (KRBH) buffer (125 mM sodium chloride, 4.74 mM potassium chloride, 1 mM calcium chloride, 1.2 mM monopotassium phosphate, 1.2 mM magnesium sulfate, 5 mM sodium bicarbonate, 25 mM 4-[2-hydroxyethyl]-1-piperazineethanesulfonic acid [HEPES] 1 mM, 0.1% BSA, pH 7.4) (Sigma-Aldrich) for 1 hour. The buffer was removed and clusters were incubated for 1 hour in KRBH buffer containing 2.8 mM glucose (low glucose concentration) and after that in KRBH buffer containing 16.7 mM glucose (high glucose concentration) for another one hour.
Statistical analyses
Data analyses and design of the graphs were performed with statistical software (GraphPad Prism 5, GraphPad Software, Inc., La Jolla, CA, USA). Analyses were performed with 1-way analysis of variance, followed by Tukey test for pairwise comparisons. In all statistical analyses, P ≤ .05 was considered statistically significant, and all values of P were 2-sided.
Results
Morphologic changes
The iPS cells before transfection were arranged in flat colonies and the cells were characterized by large nuclei and scant cytoplasm. On the first day after transfection with microRNA-7, the cells had morphologic changes and had the appearance of endodermal cells. On the second day, ILCs were partially formed. After 3 days, cell clusters were formed. On the third day, the clusters gradually detached from the bottom of the plate and floated in the medium, but the iPS cells that were transfected (Figure 1 ). On the third day, DTZ was used and the clusters appeared red in color (Figure 2 ). The zinc chelating agent DTZ quickly and specifically stained β-cells red, 19 thereby suggesting the existence of ILCs in the plate. Moreover, differentiation of the IPS cells into ILCs was achieved by 31 days. In stage 4, the differentiated cells aggregated into ILCs. 20 
Optimization of chemical transfection
The iPS cells were transfected with nontargeting negative control (FAM-labeled Pre-microRNA). The cells with the highest percentage of FAM-labeled cells (29.44%) were cells that had been transfected once and after 24 hours were analyzed by flow cytometry (Figure 3 ).
expression profile of microRNA-7 in human IPS cells
The RT-PCR was used to determine the modification at the expression of microRNA-7 in iPS cells before (day 0) and after transfection (day 1). The level of microRNA-7 increased by 107-fold in iPS cells 24 hours after chemical transfection.
expression of pancreatic-specific transcription factors during differentiation of induced pluripotent stem cells to isletlike cell clusters
The expression of pancreatic-specific transcription factors such as insulin, NGN3, GLUT2, PAX4, PAX6, KIR6.2, NKX6.1, PDX1, glucagon, and OCT-4 was performed before transfection on days 1 and 2, when morphologic changes were observed (Figure 4 ). Increased expression of pancreatic-specific transcription factors suggested that microRNA-7 induced the differentiation of IPS cell to ILCs.
Insulin secretion
The generated ILCs on day 3 showed insulin secretion upon glucose stimulation, 8.9 μIU/mL insulin secretion at 2.8 mM glucose, and 12.3 μIU/mL at stimulated glucose levels (16.7 mM glucose). However, undifferentiated iPS cells showed 7.2 μIU/mL insulin secretion at 16.7 mM glucose ( Figure 5 ).
Immunocytochemistry and isletlike cell clusters
The clusters were stained for Insulin and Neurogenin ( Figures 3A and 3B) . 
Identification the target genes of miR-7
The target genes of microRNA-7 were investigated by miRTarBase, Miranda (miRBase), and Target ScanS. These genes included GATA6, insulin receptor substrate 2 (IRS-2), IRS-1, Pax6, Pax4, NeuroD1, and Nkx2.2. These genes played regulatory roles in differentiation of pancreatic islet cells. 33 
Discussion
Developing alternative ways to restore pancreatic β-cell mass in patients with diabetes is a challenging problem. Human ES cells provide an alternative cell source for regenerative medicine in diabetes because they are characterized by unlimited self-renewal and the ability to differentiate into ILCs. 2, 21 Recent studies have shown that the endoderm and pancreatic lineages derived from human ES cells may be a good source for therapeutic purpose. The generation of functional ILCs from human ES and iPS cells with special growth factors also has been investigated. Due to the variation between human ES cells lines, challenges exist for reproducing differentiation. [22] [23] [24] Shi and associates generated insulin-producing cells from murine ES cells by using activin A, retinoic acid, and bFGF in a 3-step experimental approach. 4 Xu and coworkers investigated the differentiation of human ES cells into insulin producing cells by using bFGF, activin A, bone morphogenetic protein 4 (BMP4), ITS, GF7, and nicotinamide. 25 Moreover, Alipio and associates studied the production of β-cells from mouse IPS cells by laminin, insulin, nicotinamide, selenic acid, transferrin, and progesterone. 3 Although stem cell therapy is a promising choice for treatment of diabetic patients, human iPS cells derived from diabetic patients are the best source for cell therapy. Thatava and coworkers generated iPS cells from a diabetic patient and differentiated these cells to insulin producing cells. 26 We also produced insulin producing cells from human IPS cells after 23 days with bFGF and nicotinamide. 20 . (B, C, D, e, F, G, H, I, J) The expression of PDX1, PAX4, PAX6, KIR6.2, NKX6.1, NGN3, GLUT2, insulin, and glucagon genes significantly increased on the second day. The data are shown as mean ± SD with triplicates for each stage. Analysis were performed by 1-way analysis of variance followed by Tukey test. On the third day, the clusters were incubated with 2.8 and 16.7 mM glucose for 1 hour. The response to insulin secretion was evaluated after 1 hour incubation and the results were compared with results from the control group (transfected induced pluripotent stem [iPS] cells with nontargeting negative control [6-carboxyfluorescein-labeled pre-microRNA, Ambion]). Bars represent mean ± SD for 3 independent experiments. ***P < .0001, significantly different from the control group. Analysis was performed by 1-way analysis of variance followed by Tukey test. The microRNANAs have major effects on posttranscriptional regulation of gene expression via interaction with specific sites located in the 3′ untranslated region of target mRNAs. Researchers have investigated the function and role of microRNANAs in generation of different cells in the human body. 8 The microRNAs also are effective in promoting the differentiation of somatic stem cells to neurons, cardiomyocytes, skin, and brain tissue. [27] [28] [29] [30] [31] [32] In addition, microRNAsplay a critical role in pancreatic development. 13, [33] [34] [35] [36] However, the actions of microRNAs in the differentiation process are poorly understood. Chen and associates investigated the expression pattern of microRNAs during differentiation of human ES cells to ILCs. 17 Furthermore, Wei and coworkers induced human ES cells into insulin-producing cells in a stepwise process in vitro and analyzed the expression of some microRNAs during the differentiation process; the pattern was compared with normal development of human pancreatic islets. 21 According to their results, the expression patterns of microRNA-375 and microRNA-7 were similar to the development of human fetal pancreas. Other studies showed that microRNA-7, microRNA-9, microRNA-375, and microRNA-376 had high expression levels during pancreatic islet development in humans. 33 The microRNA-7 has also an important role in β-cell function. 14, [34] [35] [36] To obtain sufficient functional ILCs in a short time, we differentiated human iPS cells through in vitro chemical transfection by microRNA-7. The expression level of microRNA-7 was low in iPS cells before the transfection. Yet, the increased level of microRNA-7 after the transfection coincided with iPS cell differentiation into ILCs in vitro. The ILCs were successfully produced on the second day. The clusters were characterized by the expression of pancreatic specific transcription factors and were stained for insulin and neurogenin-3 proteins. The cells were stained with DTZ and secreted insulin in response to high glucose concentration in the culture medium.
In the human fetus, the expression of microRNA-7 starts from the ninth week of gestation and reaches maximum expression at the peak of pancreatic endocrine development. 25 During the specification to β-and α-cells, the expression of microRNA-7 is maintained in pancreatic endocrine cells. 37 A network of transcription factors are involved in the development of different pancreatic endocrine cell types, including insulin-producing β-cells, glucagonproducing α-cells, somatostatin-producing delta cells, pancreatic peptide-producing cells, and ghrelin-producing epsilon cells. 37 It is believed that neurogenin-3 initiates the endocrine differentiation program and Pax6 acts downstream to neurogenin-3. Kredo-Russo and coworkers found that microRNA-7 directly targeted Pax6 3' untranslated region. 37 Upon microRNA-7 knockdown, Pax6 mRNA level downregulated the transcription factors that were essential for α-cells (Arx) and β-cells (Pax4 and MafB). The levels of the exocrine transcription factor Ptf1a were unchanged. The insulin and glucagon levels increased both in the RNA and protein levels. The authors concluded that microRNA-7 limited Pax6 expression levels and controlled precise endocrine cell maturation in the development of the pancreas. 37 Bioinformatics and computational algorithms suggested that microRNA-7 has effects on targets, such as Hnf1β and Pax6, during pancreatic development. 20, 38, 39 The Pax6 up-regulation predominantly causes an increase in glucagon and Arx levels. [40] [41] [42] The β-and α-cells showed different sensitivity to Pax6 levels. This difference may be related to Pax4 expression in β-cells or additional molecular components that are not yet known. 43 Jensen and associates believed that microRNA-7 neurogenin-3 expression coincided with early expression of endocrine transcription factors NeuroD/β2. 44 In another study, it was documented that neurogenin-3 and NeuroD1 played a central role in pancreas endocrine development. This function was applied through E boxes (consensus sequence CAxxTG) located in target gene promoters, and 2 conserved E-box elements were identified in microRNA-7 promoter sequences. 45 Kredo-Russo and coworkers observed that microRNA-7 was activated by the endocrine specific transcription factor NeuroD/β2 and suggested that the cascade neurogenin-3-NeuroD/β2-microRNA-7 may have functional roles in controlling endocrine cell development posttranscriptionally. 37 Recently, Wang and coworkers suggested a new function for microRNA-7 in mouse adult pancreatic islets, which was different from its function during embryogenesis. 46, 47 The microRNA-7a is enriched in mouse adult pancreatic islets and targets the com-ponents of the mTOR signaling pathway. This pathway has a critical role in β-cell number and size and metabolic diseases such as diabetes. Activation of mTORC in mouse β cells was associated with decreased blood glucose levels and hyper-insulinemia. 48, 49 Wang and associates observed that microRNA-7a inhibition coincided with activation of mTOR signaling and promoted adult β-cell replication in adult mouse primary islets. 46 Inhibition of microRNA-7 during early pancreas development results in decreased β-cell numbers and ocurrence of postnatal diabetes. 50 These results indicate that the microRNA-7-mTOR axis has a distinct regulatory role in the developing pancreas than the mature islets.
In summary, our study revealed that overexpression of microRNA-7 may be an alternative strategy for promoting the differentiation of IPS cells toward ILCs. However, a complex network of microRNAs and transcription factors participated in β-cell differentiation, and better understanding of this process is useful for in vitro maturation of β-cells. We discussed microRNA-7-related targets through bioinformatic analysis. Therefore, more sophisticated methods, such as luciferase assay and Western blot, are necessary to analyze the expression of the possible targets.
